E70.32 - Oculocutaneous albinism
- Applicable to Oculocutaneous albinism
- The 2025 edition of ICD10-CM E70.32 became effective on October 1, 2024.
- This is the American ICD10-CM version of E70.32 - other international versions of ICD10 E70.32 may differ.
- E70.32 is a Non-Billable / Non-Specific ICD10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- E70.32 Code should not be used for billing or reimbursement purposes as there are multiple ICD-10 CM codes below it that contain a greater level of detail.
- E70.32 - Oculocutaneous albinism
- E70.32 - Oculocutaneous albinism
- E70.320 - Tyrosinase negative oculocutaneous albinism
- E70.321 - Tyrosinase positive oculocutaneous albinism
- E70.328 - Other oculocutaneous albinism
- E70.329 - Oculocutaneous albinism, unspecified
Type 1 Excludes
- Chediak-Higashi syndrome (E70.330)
- Hermansky-Pudlak syndrome (E70.331)
The following codes above E70.32 contain annotation back-references that may be applicable to E70.32:
Chapter: E00-E89 Endocrine, nutritional and metabolic diseases
Section: E70-E88 Metabolic disorders
Category: E70 Disorders of aromatic amino-acid metabolism
Non-Billable/Non-Specific Code
Browse other similar CM codes
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.
Please, give attribution to our website icd-10code.com